Becton, Dickinson and Company BDX Greater Asia — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Becton, Dickinson and Company in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Becton, Dickinson and Company’s 10-K, filed November 25, 2025, on SEC EDGAR. View the filing →
Ask your AI about Becton, Dickinson and Company's greater asia — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Becton, Dickinson and Company's greater asia — revenue?
- Becton, Dickinson and Company (BDX) reported greater asia — revenue of $773.25M in Q3 2025.
- How has Becton, Dickinson and Company's greater asia — revenue changed year-over-year?
- Becton, Dickinson and Company's greater asia — revenue increased by 6.4% year-over-year, from $726.5M to $773.25M.
- What is the long-term trend for Becton, Dickinson and Company's greater asia — revenue?
- Over 4 years (2021 to 2025), Becton, Dickinson and Company's greater asia — revenue has grown at a 0.2% compound annual growth rate (CAGR), from $3.07B to $3.09B.
- What does greater asia — revenue mean?
- This metric represents the total net sales generated by the company's operations within the Greater Asia geographic region. It reflects the market demand for medical devices, diagnostic systems, and surgical products in this specific territory. Tracking this revenue stream helps investors assess the company's regional market penetration and growth trajectory in emerging and established Asian healthcare markets.